Swiss medtech firm Implantica plans stock market listing Medical Dialogues Bureau23 Sept 2018 9:33 AM ISTImplantica regularly reviews available financing alternatives to finance the commercialization of its first implant, RefluxStop, and to accelerate the...
Mylan, Biocon bag Positive CHMP opinion for pegfilgrastim biosimilar, Fulphila Medical Dialogues Bureau23 Sept 2018 9:00 AM ISTBiocon and pharma firm Mylan said CHMP has a positive opinion recommending approval for their pegfilgrastim biosimilar, Fulphila.New Delhi:...
CCI investigation points to unfair practices by 3 pharma companies Medical Dialogues Bureau22 Sept 2018 5:44 PM ISTNew Delhi: Three prominent pharmaceutical companies are now under the radar of the Competition Commission of India (CCI) has started an initial...
Sun Pharma gets Australia TGA nod for ILUMYA to treat plaque psoriasis Medical Dialogues Bureau22 Sept 2018 12:38 PM ISTILUMYA used for the treatment of adults with plaque psoriasis. The program is designed to supplement the support offered by doctors in their practice...
Aspen Pharma suffers week of woe as valuation tumbles by $3 billion Medical Dialogues Bureau22 Sept 2018 9:42 AM ISTThe Aspen Pharma share price has tumbled more than 35 per cent since it posted full-year results and announced the baby milk disposal to French dairy...
Takeda gets European panel nod for Alunbrig to treat lung cancer Medical Dialogues Bureau22 Sept 2018 9:33 AM ISTThe European Medicines Agency's Committee for Medicinal Products for Human Use recommended granting Japan-based Takeda's Alunbrig, or brigatinib, a...
Australian Competition and Consumer Commission clears Arrow ,Apotex merger: Strides Medical Dialogues Bureau21 Sept 2018 1:15 PM ISTStrides Pharma Science Thursday said the Australian Competition and Consumer Commission (ACCC) has decided not to oppose the merger of generic pharma...
AstraZeneca plots China robot offensive to counter price cuts Medical Dialogues Bureau21 Sept 2018 9:02 AM ISTWUXI, China/LONDON: With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest...
EU approves fifth copy of AbbVie's $18 Billion drug Humira Medical Dialogues Bureau21 Sept 2018 9:00 AM ISTLONDON: Europe has approved a fifth copy of AbbVie's $18-billion-a-year biologic drug Humira - the world's best-selling prescription medicine -...
Paras Healthcare appoints Devendra Kumar Punia as Corporate Head - IT Medical Dialogues Bureau20 Sept 2018 3:17 PM ISTIn this new journey as Head- IT in Paras healthcare group, my strengths and responsibilities will rely on leveraging more data resources to deliver...
California: Drugmaker paid doctors to overprescribe Humira Medical Dialogues Bureau20 Sept 2018 1:52 PM ISTPharmaceutical giant AbbVie illegally plied doctors with cash, gifts, and services to prescribe one of the world's best-selling drugs, Humira, despite...
Biopharmaceutical company fined for misleading investors Medical Dialogues Bureau20 Sept 2018 1:48 PM ISTBOULDER, Colo. - A Colorado-based biopharmaceutical company has been penalized more than $20 million for misleading investors about the efficacy of a...
